JP2004522945A - スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ２に関連する組成物及び方法 - Google Patents

スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ２に関連する組成物及び方法 Download PDF

Info

Publication number
JP2004522945A
JP2004522945A JP2002546211A JP2002546211A JP2004522945A JP 2004522945 A JP2004522945 A JP 2004522945A JP 2002546211 A JP2002546211 A JP 2002546211A JP 2002546211 A JP2002546211 A JP 2002546211A JP 2004522945 A JP2004522945 A JP 2004522945A
Authority
JP
Japan
Prior art keywords
polypeptide
staau
seq
compound
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002546211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004522945A5 (https=
Inventor
ペルティエ，ジェリー
グロ，フィリップ
デュボー，マイケル
ベルジュロン，ドミニク
Original Assignee
ファゲテック，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/727,892 external-priority patent/US20040091856A1/en
Application filed by ファゲテック，インコーポレイティド filed Critical ファゲテック，インコーポレイティド
Publication of JP2004522945A publication Critical patent/JP2004522945A/ja
Publication of JP2004522945A5 publication Critical patent/JP2004522945A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
JP2002546211A 2000-12-01 2001-11-30 スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ２に関連する組成物及び方法 Pending JP2004522945A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/727,892 US20040091856A1 (en) 1999-12-01 2000-12-01 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
US88556101A 2001-06-20 2001-06-20
PCT/CA2001/001754 WO2002044718A2 (en) 2000-11-30 2001-11-30 S.aureus protein staau r2, gene encoding it and uses thereof

Publications (2)

Publication Number Publication Date
JP2004522945A true JP2004522945A (ja) 2004-07-29
JP2004522945A5 JP2004522945A5 (https=) 2005-07-07

Family

ID=27111604

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002546211A Pending JP2004522945A (ja) 2000-12-01 2001-11-30 スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ２に関連する組成物及び方法

Country Status (5)

Country Link
EP (1) EP1340079A2 (https=)
JP (1) JP2004522945A (https=)
AU (2) AU2042202A (https=)
CA (1) CA2428595A1 (https=)
WO (1) WO2002044718A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116908265B (zh) * 2023-09-11 2023-12-12 常州先趋医疗科技有限公司 检测核酸lamp扩增产物电化学生物传感器的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774841B2 (en) * 1998-12-03 2004-07-08 Targanta Therapeutics Inc. Development of novel anti-microbial agents based on bacteriophage genomics
EP1242611A4 (en) * 1999-12-22 2004-08-11 Phagetech Inc COMPOSITIONS AND METHODS USING AN ESSENTIAL STAPHYLOCOCUS AUREUS GENE AND ITS ENCODED PROTEIN

Also Published As

Publication number Publication date
CA2428595A1 (en) 2002-06-06
WO2002044718A2 (en) 2002-06-06
AU2002220422B2 (en) 2007-06-28
AU2002220422B9 (en) 2002-06-11
AU2042202A (en) 2002-06-11
WO2002044718A3 (en) 2002-12-12
EP1340079A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
JP2001527382A (ja) スタフィロコッカス・アウレウス由来のフェニルアラニル−ｔＲＮＡシンセターゼ
JPH11187888A (ja) ｆｔｓＺ
JP2002516868A (ja) ｎｒｄＥ
US7326541B2 (en) Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof
JP2004522945A (ja) スタフィロコッカス・アウレウス必須遺伝子及びそのコードされるタンパク質ｓｔａａｕ＿ｒ２に関連する組成物及び方法
JPH11146794A (ja) ｍｒａＹ
JPH11253171A (ja) ｄｅｘＢ
AU2002224692B2 (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein STAAU_R4
JP2002503445A (ja) 新規ｐｔｈ
US7101969B1 (en) Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US20040137516A1 (en) DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
AU2002220422A1 (en) S.aureus protein STAAU R2, gene encoding it and uses thereof
JP2002300888A (ja) ＭｕｒＣ
JP2003517833A (ja) スタフィロコッカス・アウレウス必須遺伝子とそれにコードされるタンパク質に関連する組成物と方法
JP2002522010A (ja) ｎｒｄＦ
JPH11137248A (ja) ＭｕｒＡ
JP2002540758A (ja) Ａｍａ
JP2002525044A (ja) ｔｏｐＡ
JP2002512777A (ja) 新規なｐｙｒＨ
JPH11253176A (ja) ＭｕｒＦ
JP2003533546A (ja) Ｍｕｒａ活性をモジュレーションする方法
JPH11178587A (ja) ヒスチジンキナーゼ
JP2002522059A (ja) ｎｒｄＥ
JPH11253178A (ja) Ａｂｃ輸送体
JP2002516081A (ja) 呼吸ニトレートレダクターゼアルファサブユニット

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080328

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080404

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080909